It has been shown that it also enhances proliferation and migration in triple-negative breast cancer (TNBC) cells [90], as well as migration and invasion in neuroblastoma cells [91], through regulating expression of E-cadherin (CDH1), matrix metalloproteinase 2 (MMP2) and matrix metalloproteinase 9 (MMP9) proteins [91]. The gene discussed is MMP9; the disease is neuroblastoma.